Healthcare Services Group Inc header image

Healthcare Services Group Inc

HCSG

Equity

ISIN null / Valor 938239

NASDAQ (2026-09-04)
USD 21.82+0.51%

Healthcare Services Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Healthcare Services Group Inc is a well-established leader in providing housekeeping, laundry, dining, and nutritional services to the healthcare industry. With over 45 years of experience, the company focuses on delivering improved operational, regulatory, and financial outcomes for its clients through the implementation of efficient systems, accountability measures, and quality assurance programs. Healthcare Services Group Inc places a strong emphasis on training and developing its team members at all levels to ensure excellence in service delivery. The company's foundation lies in its Environmental Services division, which has been instrumental in supporting infection prevention and control initiatives in numerous communities nationwide for over four decades.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (02.09.2026):

Healthcare Services Group, Inc.'s fourth quarter of 2025 (Q4 2025) results showed continued revenue and profit growth: revenue was $466.7 million for the quarter (up 6.6%) and $1.84 billion for the year (up 7.1%), net income was $31.2 million for the quarter ($0.44 diluted EPS) and $59.1 million for the year ($0.81 diluted EPS), with solid adjusted cash flow and an active capital return program alongside a mid-single-digit revenue growth outlook for 2026.

Revenue and segments

Q4 revenue: $466.7M (+6.6% y/y). FY 2025 revenue: $1.84B (+7.1% y/y). Segment detail (Q4): Environmental Services $210.8M (margin 12.6%); Dietary Services $255.9M (margin 7.2%).

Profitability

Q4 net income $31.2M; diluted EPS $0.44. FY net income $59.1M; diluted EPS $0.81. Operating income for Q4 was $25.9M; Adjusted EBITDA for Q4 $33.2M (7.1% of revenue).

Costs and margin targets

Q4 cost of services was $394.6M (84.6% of revenue). SG&A (adjusted for deferred comp) was $45.8M (9.8% of revenue). Company targets for 2026: cost of services in the ~86% range and SG&A in 9.5%–10.5% (longer‑term 8.5%–9.5%).

Cash flow and liquidity

GAAP cash flow from operations Q4 $17.4M; adjusted for payroll timing $36.4M. FY GAAP cash flow $145.0M; adjusted $164.1M. Cash and marketable securities combined ~$203.9M and ~$300M of undrawn revolving credit available.

Share repurchases and capital allocation

Completed $50.0M buyback program early and repurchased $61.6M in 2025. Board authorized up to 10.0M shares and a new $75.0M repurchase program over the next 12 months, with plans to accelerate buybacks.

Tax rate and other items

Q4 effective tax rate reflected a 9.4% benefit (includes an $8.3M ERC benefit); FY effective tax rate 13.0%. Company expects its 2026 effective tax rate to be approximately 25%.

2026 outlook

Healthcare Services Group, Inc. expects mid-single-digit revenue growth in 2026 and reiterated focus on executing strategic priorities to drive sustainable, profitable growth.

Summarized from source with an LLMView Source

Key figures

38.5%1Y
85.9%3Y
-17.7%5Y

Performance

41.7%1Y
41.2%3Y
41.0%5Y

Volatility

Market cap

1498 M

Market cap (USD)

Daily traded volume (Shares)

593,954

Daily traded volume (Shares)

1 day high/low

11.585 / 11.22

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 102.92
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%USD 158.63
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%SEK 454.80
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%GBP 25.85
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.50%SEK 95.00
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%SEK 587.00
DBV Technologies SA
DBV Technologies SA DBV Technologies SA Valor: 2857349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.54%EUR 2.31
CVS Group PLC
CVS Group PLC CVS Group PLC Valor: 3457960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 13.16
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.13%USD 86.35
Neumora Therapeutics Inc
Neumora Therapeutics Inc Neumora Therapeutics Inc Valor: 129329732
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.96%USD 1.31